Strong Revenue Growth
Third quarter revenues of $913 million, an increase of 19.4% year-over-year on a GAAP basis. Adjusted revenues were $892.9 million, up 16.8% year-over-year on a reported basis and up 15.3% on an adjusted constant currency basis.
Vascular Intervention Business Performance
The acquired Vascular Intervention business performed well with a 6.9% year-over-year growth, modestly exceeding expectations.
Successful Integration of Vascular Intervention
Integration activities for the acquired Vascular Intervention business are well underway and remain on track.
Positive Impact of Italian Payback Measure
Legislative changes in Italy resulted in a $23.7 million decrease in reserve, positively affecting EMEA revenue.
Expansion of Barrigel in Japan
Launched Barrigel in Japan, marking a significant milestone in its global expansion.